eISSN: 1731-2515
ISSN: 0209-1712
Anestezjologia Intensywna Terapia
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
Search
2/2020
vol. 52
 
Share:
Send email
Share:
abstract:
Review article

COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?

Katarzyna Kotfis
1
,
Shawniqua Williams Roberson
2, 3, 4
,
Jo Ellen Wilson
2, 5, 6
,
Brenda T. Pun
2
,
E. Wesley Ely
2, 6, 7
,
Ilona Jeżowska
8
,
Maja Jezierska
9
,
Wojciech Dabrowski
9

  1. Klinika Anestezjologii, Intensywnej Terapii i Ostrych Zatruć, Pomorski Uniwersytet Medyczny w Szczecinie, Polska 
  2. Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, United States
  3. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, United States
  4. Department of Bioengineering, Vanderbilt University, Nashville, TN, United States
  5. Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States
  6. Geriatric Research, Education and Clinical Center (GRECC), Tennessee Valley Veterans Affairs Healthcare System, Nashville, TN, United States
  7. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
  8. Integrative Counselling and Psychotherapy, The Minster Centre, Department of Psychology, Middlesex University, London, UK
  9. Katedra i Klinika Anestezjologii i Intensywnej Terapii, Uniwersytet Medyczny w Lublinie, Polska
Online publish date: 2020/07/26
View full text Get citation
 
In March 2020, the World Health Organisation announced the COVID-19 pandemic caused by the SARS-CoV-2 virus. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement, including delirium occurring in critically ill patients (ICU delirium). Due attention must be paid to this subject in the face of the COVID-19 pandemic. Delirium, the detection of which takes less than two minutes, is frequently underestimated during daily routine ICU care, but it may be a prodromal symptom of infection or hypoxia associated with severe respiratory failure. During the COVID-19 pandemic, systematic delirium monitoring using validated tests (CAM-ICU or ICDSC) may be sacrificed. This is likely to be due to the fact that the main emphasis is placed on organisational issues, i.e. the lack of ventilators, setting priorities for limited mechanical ventilation options, and a shortage of personal protective equipment. Early identification of patients with delirium is critical in patients with COVID-19 because the occurrence of delirium may be an early symptom of worsening respiratory failure or of infectious spread to the CNS mediated by potential neuroinvasive mechanisms of the coronavirus. The purpose of this review is to identify problems related to the development of delirium during the COVID-19 epidemic, which are presented in three areas: i) factors contributing to delirium in COVID-19, ii) potential pathophysiological factors of delirium in COVID-19, and iii) long-term consequences of delirium in COVID-19. This article discusses how healthcare workers can reduce the burden of delirium by identifying potential risk factors and difficulties during challenges associated with SARS-CoV-2 infection.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.